Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2007-02-27
2007-02-27
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S461000, C564S161000, C549S483000
Reexamination Certificate
active
10462331
ABSTRACT:
The invention concerns compounds of formula (1): R-A-R′ wherein: A is as defined in the description; R represent a group (V), (VI), (VII), or (VIII), where E, Q, R1, R2, R3, v and R4are as defined in the description; R′ represents a —(CH2)t—R5group wherein t and R5are as defined in the description, and medicaments containing the same
REFERENCES:
patent: WO-96/08466 (1996-03-01), None
Loo et al. Int. Clin. Psychopharmacol. 17(5): 239-47, 2002.
Millan et al. Psychopharmacology 177(4): 448-458, 2005.
Borchardt et. al. J. Am. Chem. Soc. 116, 7467-7468, 1994.
CASREACT 122:56495,1994. CAPLUS Abstract.
Helvetica Chimica Acta 76(4), 1539-1563, 1993. CA 120:107688, 1994.CAPLUS Abstract.
Drugs of the Future 2000, 25(9), pp. 945-957.
Cagnacci et al., J. Pineal Res., 1997, 22, pp. 16-19.
Life Sciences 2000, 66(6) pp. 503-509.
Bylesjö E.I. et al., International Journal of Eating Disorders, 1996, 20(4), pp. 443-446.
Ferrari E. et al., Biol, Phychiatry, 1990, 27, pp. 1007-1020.
Brown G.M., CNS Drugs, 1995 3(3), pp. 209-226.
Psychopharmacology 1990, 100: 222-226.
Brain Research 1990, 528m 170-174.
Schizophrenia Research 1992, 7, 77-84.
Journal of Affective Disorders 1987, 12 203-206.
Medical Hypotheses 1988, 27, 271-276.
Behavioural Pharmacology 1999, 10, 73083.
Neuropharmacology 2000, 39, 1865-71.
Exp. Brain Res.1995, 107, 321-325.
Endocrinology 1999, vol. 140(2), 1009-1012.
Medical Hypotheses 1991, 34, pp. 300-309.
Current Pharmaceutical Design 2001, 7, 909-931.
Science 1985, 227, pp. 714-720.
Rec. Med, Vet. 1991, 167(3/4), pp. 227-239.
Drug Development Research 1996, 39, pp. 167-173.
Am. J. Physiol. 1998, 275, pp. 139-144.
Leone M. et al., Cephalalgia, 1996, 16, pp. 494-496.
Cephalalgia, 1995, 15, pp. 136-139.
Shui-Wang Ying et al., Eur. Journal of Pharmacology, 1993, 246, pp. 89-96.
Laudon M. et al., Journal of clinical Endocrinology and Metabolism, 1996, 8194, pp. 1336-1342.
Lissoni P., British Journal of Cancer 1996, 74, pp. 1466-1468.
Li, et al.,Drugs of the Future,2000, 25, 945-957.
Krause, et al.,Society for Neuroscience,1996, 22, No. 651.19, p. 1400.
Vacas, et al.,J. Pineal Research,1992, 13, 60-65.
Cagnacci, et al.,J. Pineal Research,1997, 22, 16-19.
Lagneux, et al.,Life Sciences,2000, 66, 503-509.
Brydon, et al.,Endocrinology,2001, 142, 4264-4271.
Bylesjö, et al.,International Journal of Eating Disorders,1996, 20, 443-446.
Ferrari, et al.,Biol. Psychiatry,1990, 27, 1007-1020.
Mazzucchelli, et al.,Molecular Brain Research,1996, 39, 117-126.
Brown,CNS Drugs,1995, 3, 209-226.
Waldhauser, et al.,Psychopharmacology,1990, 100, 222-226.
Skene, et al.,Brain Research,1990, 528, 170-174.
Monteleone, et al.,Schizophrenia Research,1992, 7, 77-84.
Mc Intyre, et al.,Journal of Affective Disorders,1987, 12, 203-206.
Erlich, et al.,J. Neurosurg.,1985, 63, 321-341.
Maurizi,Medical Hypotheses,1988, 27, 271-276.
Kopp, et al.,Behavioural Pharmacology,1999, 10, 73-83.
Kopp, et al.,Neuorpharmacology,2000, 39, 1865-1871.
Fanteck, et al.,Exp. Brain Res.,1995, 107, 321-325.
Rasmussen, et al.,Endocrinology,1999, 140, 1009-1012.
Armstrong, et al.,Medical Hypotheses,1991, 34, 300-309.
O'Brien, et al.,Clinical Endocrinology,1986, 24, 359-364.
Motilva, et al.,Current Pharmaceutical Design,2001, 7, 909-931.
Tamarkin, et al.,Science,1985, 227, 714-720.
Chemineau, et al.,Rec. Med. Vet.,1991, 167, 227-239.
Xu, et al.,Drug Development Research,1996, 39, 167-173.
Regrigny, et al.,Am. J. Physiol.,1998, 275, 139-144.
Stankov, et al.,Neuroscience,1993, 52, 459-468.
Leone, et al.,Cephalalgia,1996, 16, 494-496.
Brun, et al.,Cephalalgia,1995, 15, 136-139.
Ying, et al.,Eur. J. of Pharmacology,1993, 246, 89-96.
Laudon, et al.,Journal of Clinical Endocrinology and Metabolism,1996, 81, 1336-1342.
Lissoni, et al.,British Journal of Cancer,1996, 74, 1466-1468.
Bennejean Caroline
Delagrange Philippe
Guillaumet Gerald
Klupsch Frédérique
Langlois Michel
Balasubramanian Venkataraman
Hueschen and Sage
Les Laboratoires Servier
LandOfFree
Substituted cyclic compounds, preparation method and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cyclic compounds, preparation method and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclic compounds, preparation method and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3875766